A
Albert Labs International Corp
F:VB50
Albert Labs International Corp
F:VB50
Price:
0.005
EUR
Market Closed
Market Cap:
€372.1k
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
A
|
Albert Labs International Corp
F:VB50
|
CA |
|
B
|
Boutique Corporation PCL
SET:BC
|
TH |
|
M
|
Mega Lifesciences PCL
SET:MEGA
|
TH |
|
I
|
Inter Pharma PCL
SET:IP
|
TH |
|
F
|
Future City Leasehold Real Estate Investment Trust
SET:FUTURERT
|
TH |
Intrinsic Value
Not Available for VB50
There is not enough data to reliably calculate the intrinsic value for Albert Labs International Corp.
Do our valuations actually work? See backtest results .
Alternatives to VB50
Fundamental Analysis
What Albert Labs International Does
Albert Labs International Corp. operates as a research and drug development company. The company is headquartered in Surrey, British Columbia. The company went IPO on 2010-04-29. The firm is a laboratory-based, clinical research and drug development enterprise addressing mental health care needs. The firm focuses on treating patients with urgent and unmet mental health needs, starting with cancer-related anxiety.
- Headquarters
- Canada CA
- IPO date
- Apr 29, 2010
Financials
Efficiency
Earnings Waterfall
Albert Labs International Corp
Albert Labs International Corp
